To determine the inhibition of breast cancer cell proliferation by synthetic (±)-kusunokinin, four final proteins of the HER2 pathway were examined, including c-Myc, CyclinB1, CyclinD1 and CDK1 using Western blot analysis (Figure 7A). This evidence concerns the gene ERBB2 and breast carcinoma.